Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Non-small Cell Lung”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00003329
What this trial is testing

Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer

Who this might be right for
Breast CancerColorectal CancerLung Cancer+1 more
Eastern Cooperative Oncology Group 4,000
Testing effectiveness (Phase 2)Study completedNCT00069875
What this trial is testing

A Study With Gemcitabine, Cisplatin, and LY293111 in Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Eli Lilly and Company 195
Not applicableStudy completedNCT03782207
What this trial is testing

A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice

Who this might be right for
Urothelial CarcinomaNon-Small Cell Lung CancerSmall Cell Lung Cancer+1 more
Hoffmann-La Roche 2,756
Testing effectiveness (Phase 2)Study completedNCT01130753
What this trial is testing

Efficacy of Erlotinib in Neoadjuvant Setting in Patients With Stage IIIA, N2-positive Non-Small Cell Lung Cancer

Who this might be right for
Lung NeoplasmsErlotinibNeoadjuvant Therapy
Samsung Medical Center 43
Testing effectiveness (Phase 2)UnknownNCT01210053
What this trial is testing

Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Third Military Medical University 30
Early research (Phase 1)Looking for participantsNCT06800339
What this trial is testing

A Study Evaluating Neoadjuvant Chemoimmunotherapy With Immunosensitizing Radiation for Borderline Resectable Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
University of Maryland, Baltimore 18
Post-approval studies (Phase 4)UnknownNCT02404675
What this trial is testing

High Dose Icotinib in Advanced Non-small Cell Lung Cancer With EGFR 21 Exon Mutation

Who this might be right for
NSCLC
Betta Pharmaceuticals Co., Ltd. 240
Not applicableApproved For MarketingNCT04599712
What this trial is testing

Pre-Approval Access With Amivantamab (JNJ-61186372) in Participants With Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Metastatic Non-Small Cell Lung Cancer
Janssen Research & Development, LLC
Testing effectiveness (Phase 2)Study completedNCT00126581
What this trial is testing

Erlotinib Hydrochloride With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III-IV Non-small Cell Lung Cancer

Who this might be right for
Lung AdenocarcinomaLung Adenosquamous CarcinomaMalignant Pericardial Effusion+4 more
National Cancer Institute (NCI) 188
Not applicableEnded earlyNCT01567722
What this trial is testing

Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies

Who this might be right for
Lung CancerLymphoma
AIDS Malignancy Consortium 114
Early research (Phase 1)Study completedNCT03421353
What this trial is testing

AZD9150 Plus Durvalumab Alone or in Combination With Chemotherapy in Patients With Advanced, Solid Tumours and in Patients With Non-Small-Cell Lung Cancer

Who this might be right for
Advanced Solid Tumours
AstraZeneca 76
Very early researchUnknownNCT05886075
What this trial is testing

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors

Who this might be right for
Lung CancerBronchial CancerNon Small Cell Lung Cancer+9 more
Shanghai Yunying Medical Technology 24
Large-scale testing (Phase 3)Active Not RecruitingNCT05870319
What this trial is testing

A Phase III Study of SKB264 for EGFR Mutant NSCLC Patients

Who this might be right for
Non-small Cell Lung Cancer
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 376
Early research (Phase 1)Not Yet RecruitingNCT07318636
What this trial is testing

NK-cell Therapy Combined With PD-1 Antibody and Platinum-Based Chemotherapy as Neoadjuvant Therapy in Resectable NSCLC

Who this might be right for
Resectable Non-small Cell Lung Cancer
The First Affiliated Hospital of Guangzhou Medical University 10
Testing effectiveness (Phase 2)Looking for participantsNCT05766800
What this trial is testing

Induction Therapy With PD-1 Antibody Combined With Platinum-based Doublet Chemotherapy for Locally-advanced Non-small Cell Lung Cancer

Who this might be right for
Locally AdvancedNon-small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 100
Testing effectiveness (Phase 2)Study completedNCT01924195
What this trial is testing

Phase II Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer（ALTER0302）

Who this might be right for
Non-small Cell Lung Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 117
Large-scale testing (Phase 3)Study completedNCT01905657
What this trial is testing

Study of Two Doses of Pembrolizumab (MK-3475) Versus Docetaxel in Previously Treated Participants With Non-Small Cell Lung Cancer (MK-3475-010/KEYNOTE-010)

Who this might be right for
Non Small Cell Lung Cancer (NSCLC)
Merck Sharp & Dohme LLC 1,034
Early research (Phase 1)WithdrawnNCT01004419
What this trial is testing

Trial of ZD6474 and Faslodex in Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non Small Cell Lung
University of Wisconsin, Madison
Testing effectiveness (Phase 2)UnknownNCT05801107
What this trial is testing

Study to Investigate the Efficacy and Safety of WX-0593 in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients

Who this might be right for
Non-small Cell Lung Cancer
Qilu Pharmaceutical Co., Ltd. 30
Testing effectiveness (Phase 2)Looking for participantsNCT06902272
What this trial is testing

CtDNA to Predict Response to Chemo-Immunotherapy and Detect Minimal Residual Disease in Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
University of Miami 30
Next Page